小児肝移植医療における免疫抑制療法
書誌事項
- タイトル別名
-
- Immunosuppresssion in pediatric liver transplantation
抄録
Recent advances in immunosuppression(IS)have improved the outcomes in pediatric liver transplantation(LT). Particular attention should be paid to several difference between children and adults in IS for LT. Better understanding of the pharmacokinetics of immunosuppressants in children is one of the most important issues, although data on this aspect are still insufficient. Controling alloreactivity by appropriate IS is crucial for the success of pediatric LT. In our series of pediatric living donor LT, younger children suffering from acute liver failure often encountered steroid-resistant rejection after LT. The selection of immunosuppressive agents must be clues to overcome steroid-resistant rejection. Epstein-Barr virus(EBV)is also one of the major topics in pediatric LT. Monitoring of EBV-viral DNA load and lymphocyte surface markers may be effective to control EBV infection after LT. Basic and clinical epoch-making data related to immune tolerance have been reported in pediatric recipients undergoing living donor LT in Kyoto, which may bring significant benefits to pediatric LT in the near future.
収録刊行物
-
- Organ Biology
-
Organ Biology 20 (2), 222-226, 2013
一般社団法人 日本臓器保存生物医学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390282680489667840
-
- NII論文ID
- 130004710071
-
- ISSN
- 21880204
- 13405152
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可